The term demyelination refers to the loss of the myelin sheath that surrounds and protects axons in the central nervous system. Demyelination occurs as the result of diseases that damage the myelin ...

This page lists all known medications that could potentially lead to 'Osmotic demyelination syndrome' as a side effect. It's important to note that mild side effects are quite common with medications.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated neuropathy. It affects peripheral nerves and roots. CIDP has no biomarkers. It may be monophasic or ...

Findings from a retrospective study comparing typical and myelocortical multiple sclerosis (MS) identified major pathological differences between the 2 MS subtypes and determined that demyelination ...

Pembrolizumab and nivolumab, two humanized antibodies against programmed cell death 1 (PD-1) receptor, were recently approved for the treatment of unresectable or metastatic melanoma and for other ...

Demyelination – a term that might sound like scientific jargon but has real-world implications for many. Demyelination occurs when the protective covering of nerve fibers in the brain, spinal cord, ...

A preclinical study by biomedical scientists at the University of California, Riverside, has shown why some people with multiple sclerosis, or MS, also suffer from seizures — a debilitating ...

Classic chronic inflammatory demyelinating polyneuropathy is characterized by the occurrence of symmetrical weakness in both proximal and distal muscles that progressively increases for more than two ...